Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer)
Medically reviewed by Drugs.com. Last updated on May 15, 2022.
Although the licensed vaccine (Comirnaty(R)) is FDA-approved in patients aged 16 or older for 2 doses , Pfizer-BioNTech COVID-19 vaccine is an unapproved product authorized for emergency use in individuals aged 12 through 15 years and to provide a third dose to individuals aged 12 years or older who are solid organ transplant recipients or have an equivalent level of immunocompromise .
Available Dosage Forms:
- Suspension
Therapeutic Class: COVID-19 Vaccine
Uses for sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer)
SARS-CoV-2 vaccine (mRNA-LNP, spike protein) is used as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 5 years of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This vaccine is to be given only by or under the direct supervision of your doctor.
Before using sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer)
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer), the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer) or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of SARS-CoV-2 (COVID-19) vaccine supplied in vials with gray caps or vials with purple caps in children 12 years of age and older, and vials with orange caps in children 5 to 11 years of age. Safety and efficacy have been established.
Appropriate studies have not been performed on the relationship of age to the effects of SARS-CoV-2 (COVID-19) vaccine in children younger than 5 years of age. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of SARS-CoV-2 (COVID-19) vaccine in the elderly.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer), it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The f..
